ArticleBMC neurology2025
Association between inflammatory markers and Parkinson's disease risk: a cross-sectional, propensity score-matched analysis of NHANES data.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundParkinson's disease (PD) is a chronic neurodegenerative disorder characterized by motor and non-motor symptoms, with neuroinflammation hypothesized to contribute to its pathogenesis. Systemic inflammation, as indicated by elevated peripheral inflammatory markers, has been implicated in PD; however, the relationship between complete blood count (CBC)-derived inflammatory markers and the presence of PD remains unclear.
methodsWe analyzed data from the National Health and Nutrition Examination Survey (NHANES) spanning 1999 to 2018, including 15,349 participants. Propensity score matching was employed to balance baseline characteristics between PD and non-PD groups. Multivariate logistic regression models were used to evaluate the association between CBC-derived inflammatory markers, particularly the neutrophil-to-lymphocyte ratio (NLR), and the presence of PD.
resultsAfter multivariable adjustment, elevated NLR was significantly associated with higher odds of PD. Individuals in the highest NLR quartile had higher odds of PD compared to those in the lowest quartile (OR: 2.18, 95% CI: 1.04-4.68; P for trend < 0.0001). This association was consistent across subgroups, including gender, diabetes status, hypertension, obesity, smoking, and alcohol consumption. Other CBC-derived markers, such as the monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), did not show consistent associations with the presence of PD.
conclusionsElevated NLR is significantly associated with the presence of PD among U.S. adults, independent of key confounders. However, due to the cross-sectional study design and reliance on self-reported PD status, causality cannot be inferred, and misclassification bias cannot be excluded. Further longitudinal studies are warranted to validate these findings and clarify the temporal relationship between systemic inflammation and PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.